Author:
Rockwood Kenneth,Fay Sherri,Gorman Mary,Carver Daniel,Graham Janice E
Publisher
Springer Science and Business Media LLC
Subject
Clinical Neurology,General Medicine
Reference29 articles.
1. Perras C, Shukla VK, Lessard C, Skidmore B, Bergman H, Gauthier S: Cholinesterase inhibitors for Alzheimer's disease: a systematic review of randomized controlled trials [Technology report no 58]. 2005, Ottawa: Canadian Consulting Office for Health Technology Assessment
2. Rockwood K, Black SE, Robillard A, Lussier I: Potential treatment effects of donepezil not detected in Alzheimer's disease clinical trials: a physician survey. Int J Geriatr Psychiatry. 2004, 19: 954-960. 10.1002/gps.1188.
3. Rockwood K, MacKnight C: Assessing the clinical importance of statistically significant improvement in anti-dementia drug trials. Neuroepidemioly. 2001, 20: 51-56. 10.1159/000054761.
4. Courtney C, Farrell D, Gray R, Hills R, Lynch L, Sellwood E, Edwards S, Hardyman W, Raftery J, Crome P, Lendon C, Shaw H, Bentham P, AD2000 Collaborative Group: Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): Randomised double-blind trial. Lancet. 2004, 363: 2105-2115. 10.1016/S0140-6736(04)16499-4.
5. Kaduszkiewicz H, Zimmermann T, Beck-Bornholdt HP, van den Bussche H: Cholinesterase inhibitors for patients with Alzheimer's disease: Systematic review of randomised clinical trials. BMJ. 2005, 331: 321-327. 10.1136/bmj.331.7512.321.
Cited by
88 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献